& Pearson, G
In agreement with expectations, the first outcome trial of a GLP-1RA, the ELIXA trial of the short-acting lixisenatide, an exendin-4 derivative with properties almost identical to those of exendin-4 or exenatide (stable, full agonists of the GLP-1 receptor), showed no increased cardiovascular risk in a patient group with severely increased CVD risk
View all products All GLP-1 Products for Texas Patients Wegovy, Zepbound, Foundayo & GLP-1 shipped to your Texas door Physician-reviewed semaglutide, tirzepatide, and orforglipron options including Wegovy, Zepbound & Foundayo personalized to your health profile with ongoing clinical support
PlexusDx offers semaglutide and tirzepatide through its Weight Management Protocols Semaglutide Injection, Semaglutide Oral, Tirzepatide Injection, and Tirzepatide Oral with genetic context as the test before you invest approach
Billon C, Schoepke E, et al
To receive new posts and support my work, consider becoming a free or paid subscriber.